Literature DB >> 22675098

Dermatomyositis masquerading musculoskeletal tuberculosis.

Sakthiswary Rajalingham1, Mohd Shahrir Mohd Said, Syahrul Sazliyana Shaharir, Aini AbAziz, Petrick Periyasamy, Fauzi Md Anshar.   

Abstract

Dermatomyositis is a rare rheumatic disease which predominantly affects the muscles and skin requiring a protracted course of immunosuppressants which may predispose the patients to opportunistic infections. A 49-year-old lady was diagnosed to have dermatomyositis in August 2010 based on history, significantly raised creatine kinase level and muscle biopsy findings. She had recurrent admissions due to fever, myalgia and muscle weakness. She had spiking temperature despite high dose steroids, broad-spectrum antibiotics and antifungal agents. This prompted extensive investigation which leads us to the additional diagnosis of disseminated tuberculosis involving the lungs, muscles and bones. This case demonstrates the challenge in controlling the disease activity of dermatomyositis with immunosuppressants in the setting of disseminated tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22675098      PMCID: PMC3207782          DOI: 10.1136/bcr.08.2011.4675

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Resistant dermatomyositis complicated by tubercular myositis and successfully treated with rituximab.

Authors:  Ramesh Jois; Nikhila Vasudevan; Pradeep Srinivasan; Ravindra Mehta
Journal:  Neurol India       Date:  2011 Mar-Apr       Impact factor: 2.117

Review 2.  Extrapulmonary tuberculosis.

Authors:  S K Sharma; A Mohan
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

3.  Dermatomyositis with tuberculous fasciitis.

Authors:  Yuichi Yoshida; Juichiro Nakayama; Masutaka Furue; Tetsuo Matsuda
Journal:  Eur J Dermatol       Date:  2004 Mar-Apr       Impact factor: 3.328

4.  [Isolated muscular tuberculosis in dermatomyositis treated with corticosteroids. Developing outbreak of dermatomyositis under rifampicin treatment. 2 cases].

Authors:  J P Camus; A C Koeger; K Nahoul; D Alcaix; L Gutmann
Journal:  Ann Med Interne (Paris)       Date:  1987

5.  Tuberculous myofasciitis in dermatomyositis.

Authors:  Chih-Hsin Liu; Wen-Chung Liu; Lee-Wei Chen; Jin-Shyr Chen
Journal:  Clin Rheumatol       Date:  2008-01-26       Impact factor: 2.980

6.  Rifampicin reduces effectiveness and bioavailability of prednisolone.

Authors:  W A McAllister; P J Thompson; S M Al-Habet; H J Rogers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

7.  Tuberculous infection of skeletal muscle in a case of dermatomyositis.

Authors:  G S Davidson; C R Voorneveld; N Krishnan
Journal:  Muscle Nerve       Date:  1994-07       Impact factor: 3.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.